GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
GlobalData on MSN8h
Are dry powder inhalers really the key to sustainable respiratory care?Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...
A new generic version of varenicline – originally sold in the UK as Champix by Pfizer – has now been approved for use by the ...
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...
pence - 'buy' Jefferies cuts GSK to 'hold' (buy) - price target 1,525 (2,000) pence Jefferies raises Ashtead price target to 6,800 (6,150) pence - 'buy' RBC raises National Grid price target to 1,150 ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and ...
GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...
Sri Lanka’s leading e-commerce platform, Daraz, has officially launched its annual 11.11 shopping festival, known as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback